www.dailypolitical.com ·
Bristol Myers Squibb Company Bmy Stock Holdings Increased by Proshare Advisors Llc
Topic context
This topic has been covered 241948 times in the last 7 days across our monitored publishers.
The full article is on the original publisher site.
AI insight
AI-generatedThe article reports a routine portfolio adjustment by an institutional investor in Bristol Myers Squibb (BMY), a large pharmaceutical company. There is no new commercial mechanism such as drug approval, pipeline update, pricing change, or supply disruption. The EPS beat and revenue growth are modest and do not indicate a material shift in the company's competitive position or margin structure. The impact is limited to BMY's stock price and is not sector-wide.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- ProShare Advisors LLC increased BMY holdings by 3.5% in Q4, owning 397,535 shares valued at $21.44 million.
- Bristol Myers Squibb reported Q4 EPS of $1.58, beating estimates.
- Revenue was $11.49 billion, up 2.6% year-over-year.
- Quarterly dividend of $0.63 declared, yield 4.3%.
- Institutional ownership at 76.41%.
Related stories
peninsuladailynews.com
Sequim Schools to Cut Staffing 2
manilatimes.net
Infinix Launches Hot 70 Series With Industry First 12 Colorway Dynamic Shine Design
jagranjosh.com
Statewise Inflation Rates of India for Based on Cpi 1820009237 1
nbr.co.nz
F and P Healthcare Weighs on Nzx50 Ahead of Earnings
adgully.com